147 related articles for article (PubMed ID: 27189828)
1. MYD88 Somatic Mutation Is a Diagnostic Criterion in Primary Cutaneous Large B-Cell Lymphoma.
Menguy S; Gros A; Pham-Ledard A; Battistella M; Ortonne N; Comoz F; Balme B; Szablewski V; Lamant L; Carlotti A; Lorton MH; de Muret A; Le Gall F; Franck F; Croue A; Cappellen D; Beylot-Barry M; Merlio JP; Vergier B
J Invest Dermatol; 2016 Aug; 136(8):1741-1744. PubMed ID: 27189828
[No Abstract] [Full Text] [Related]
2. The differential diagnosis between primary cutaneous large B-cell lymphoma and cutaneous follicular lymphoma: prognostic and therapeutic implications.
Fernandez-Flores A; Smucler-Simonovich A; Escalante F; Manjon JA
Am J Dermatopathol; 2011 Dec; 33(8):819-26. PubMed ID: 22042259
[TBL] [Abstract][Full Text] [Related]
3. MYD88 somatic mutation is a genetic feature of primary cutaneous diffuse large B-cell lymphoma, leg type.
Pham-Ledard A; Cappellen D; Martinez F; Vergier B; Beylot-Barry M; Merlio JP
J Invest Dermatol; 2012 Aug; 132(8):2118-20. PubMed ID: 22495176
[No Abstract] [Full Text] [Related]
4. Patients with primary breast and primary female genital tract diffuse large B cell lymphoma have a high frequency of MYD88 and CD79B mutations.
Cao XX; Li J; Cai H; Zhang W; Duan MH; Zhou DB
Ann Hematol; 2017 Nov; 96(11):1867-1871. PubMed ID: 28803429
[TBL] [Abstract][Full Text] [Related]
5. Identification of Somatic Mutations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type by Massive Parallel Sequencing.
Mareschal S; Pham-Ledard A; Viailly PJ; Dubois S; Bertrand P; Maingonnat C; Fontanilles M; Bohers E; Ruminy P; Tournier I; Courville P; Lenormand B; Duval AB; Andrieu E; Verneuil L; Vergier B; Tilly H; Joly P; Frebourg T; Beylot-Barry M; Merlio JP; Jardin F
J Invest Dermatol; 2017 Sep; 137(9):1984-1994. PubMed ID: 28479318
[TBL] [Abstract][Full Text] [Related]
6. High frequency and clinical prognostic value of MYD88 L265P mutation in primary cutaneous diffuse large B-cell lymphoma, leg-type.
Pham-Ledard A; Beylot-Barry M; Barbe C; Leduc M; Petrella T; Vergier B; Martinez F; Cappellen D; Merlio JP; Grange F
JAMA Dermatol; 2014 Nov; 150(11):1173-9. PubMed ID: 25055137
[TBL] [Abstract][Full Text] [Related]
7. MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma.
Takeuchi T; Yamaguchi M; Kobayashi K; Miyazaki K; Tawara I; Imai H; Ono R; Nosaka T; Tanaka K; Katayama N
Cancer; 2017 Apr; 123(7):1166-1173. PubMed ID: 27915469
[TBL] [Abstract][Full Text] [Related]
8. Primary cutaneous B-cell lymphomas with large cell predominance-primary cutaneous follicle center lymphoma, diffuse large B-cell lymphoma, leg type and intravascular large B-cell lymphoma.
Hope CB; Pincus LB
Semin Diagn Pathol; 2017 Jan; 34(1):85-98. PubMed ID: 28065463
[TBL] [Abstract][Full Text] [Related]
9. Mutational frequencies of CD79B and MYD88 vary greatly between primary testicular DLBCL and gastrointestinal DLBCL.
Frick M; Bettstetter M; Bertz S; Schwarz-Furlan S; Hartmann A; Richter T; Lenze D; Hummel M; Dreyling M; Lenz G; Gaumann A
Leuk Lymphoma; 2018 May; 59(5):1260-1263. PubMed ID: 28868954
[No Abstract] [Full Text] [Related]
10. Challenges in Assessing MYC Rearrangement in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg-Type.
Menguy S; Laharanne E; Prochazkova-Carlotti M; Gros A; Vergier B; Parrens M; Beylot-Barry M; Pham-Ledard A; Merlio JP
Am J Surg Pathol; 2020 Mar; 44(3):424-427. PubMed ID: 31764222
[No Abstract] [Full Text] [Related]
11. Acquired N-Linked Glycosylation Motifs in B-Cell Receptors of Primary Cutaneous B-Cell Lymphoma and the Normal B-Cell Repertoire.
Koning MT; Quinten E; Zoutman WH; Kiełbasa SM; Mei H; van Bergen CAM; Jansen P; Vergroesen RD; Willemze R; Vermeer MH; Tensen CP; Veelken H
J Invest Dermatol; 2019 Oct; 139(10):2195-2203. PubMed ID: 31042459
[TBL] [Abstract][Full Text] [Related]
12. Frequent MYD88 L265P and CD79B Mutations in Primary Breast Diffuse Large B-Cell Lymphoma.
Taniguchi K; Takata K; Chuang SS; Miyata-Takata T; Sato Y; Satou A; Hashimoto Y; Tamura M; Nagakita K; Ohnishi N; Noujima-Harada M; Tabata T; Kikuti YY; Maeda Y; Nakamura N; Tanimoto M; Yoshino T
Am J Surg Pathol; 2016 Mar; 40(3):324-34. PubMed ID: 26752547
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of
Schrader AMR; Jansen PM; Willemze R; Vermeer MH; Cleton-Jansen AM; Somers SF; Veelken H; van Eijk R; Kraan W; Kersten MJ; van den Brand M; Stevens WBC; de Jong D; Abdul Hamid M; Tanis BC; Posthuma EFM; Nijland M; Diepstra A; Pals ST; Cleven AHG; Vermaat JSP
Blood; 2018 May; 131(18):2086-2089. PubMed ID: 29514783
[No Abstract] [Full Text] [Related]
14. Frequency of MYD88 and CD79B mutations, and MGMT methylation in primary central nervous system diffuse large B-cell lymphoma.
Zheng M; Perry AM; Bierman P; Loberiza F; Nasr MR; Szwajcer D; Del Bigio MR; Smith LM; Zhang W; Greiner TC
Neuropathology; 2017 Dec; 37(6):509-516. PubMed ID: 28856744
[TBL] [Abstract][Full Text] [Related]
15. The expression of IgM is helpful in the differentiation of primary cutaneous diffuse large B cell lymphoma and follicle center lymphoma.
Demirkesen C; Tüzüner N; Esen T; Lebe B; Ozkal S
Leuk Res; 2011 Sep; 35(9):1269-72. PubMed ID: 21700336
[TBL] [Abstract][Full Text] [Related]
16. Primary cutaneous diffuse large B-cell lymphoma, leg type: diagnostic considerations.
Hristov AC
Arch Pathol Lab Med; 2012 Aug; 136(8):876-81. PubMed ID: 22849734
[TBL] [Abstract][Full Text] [Related]
17. PREVALENCE OF MYD88 L265P MUTATION IN HISTOLOGICALLY PROVEN, DIFFUSE LARGE B-CELL VITREORETINAL LYMPHOMA.
Raja H; Salomão DR; Viswanatha DS; Pulido JS
Retina; 2016 Mar; 36(3):624-8. PubMed ID: 26900675
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous annular lesions as the first sign of transformation of follicular lymphoma into diffuse large B-cell lymphoma.
Palacios-Álvarez I; Román-Curto C; García-Sancho AM; Santos-Briz Á; Santos-Durán JC; Fernández-López E
Indian J Dermatol Venereol Leprol; 2015; 81(5):495-7. PubMed ID: 26087101
[TBL] [Abstract][Full Text] [Related]
19. Primary cutaneous B-cell lymphomas: part I. Clinical features, diagnosis, and classification.
Suárez AL; Pulitzer M; Horwitz S; Moskowitz A; Querfeld C; Myskowski PL
J Am Acad Dermatol; 2013 Sep; 69(3):329.e1-13; quiz 341-2. PubMed ID: 23957984
[TBL] [Abstract][Full Text] [Related]
20. The importance of Myd88 L265P mutation, clinical and immunohistochemical prognostic factors for the survival of patients with diffuse large B-cell non-Hodgkin lymphoma treated by immunochemotherapy in southeast Serbia.
Tadic L; Marjanovic G; Macukanovic-Golubovic L; Krstic M; Jevtovic-Stoimenov T; Kostov M; Smelcerovic Z; Stojanovic M
J BUON; 2016; 21(5):1259-1267. PubMed ID: 27837631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
